Welcome to our dedicated page for Advent Technologies Holdng news (Ticker: ADN), a resource for investors and traders seeking the latest updates and insights on Advent Technologies Holdng stock.
Advent Technologies Holdings, Inc. (ADN) is a U.S.-based fuel cell and hydrogen technology company whose news flow centers on developments in high-temperature proton exchange membrane (HT-PEM) fuel cells, Membrane Electrode Assembly (MEA) components, and related clean power applications. The ADN news page on Stock Titan aggregates company press releases and other coverage so readers can follow how Advent’s technology and commercial relationships evolve across multiple sectors.
Recent Advent news highlights collaborations in aviation and aerospace, including work with Airbus and Stralis Aircraft on next-generation Ion Pair™ MEA technology for hydrogen-electric propulsion and electric flight. Other articles describe Advent’s initiatives in the space sector with the European Space Agency, where its HT-PEM systems are being explored for satellite and spacecraft power when solar-based systems are insufficient.
Advent’s news also covers defense and portable power, such as deliveries of Honey Badger 50™ portable fuel cell units to the U.S. Army under contracts with the U.S. Department of Defense. Additional releases discuss supply agreements for MEAs with companies like Siqens GmbH and a European transportation power company, as well as the EU-funded RHyno Project to build manufacturing infrastructure for fuel cells, electrolysers, and key components at megawatt scale.
Investors and industry observers can use this page to track announcements about technology milestones, funded projects, supply contracts, capital markets activity, and listing status updates, including Nasdaq delisting proceedings and OTC trading plans for ADN and ADNWW. Bookmark this feed to monitor how Advent’s stated strategy in fuel cells, hydrogen technologies, and energy storage is reflected in its ongoing news and regulatory communications.
Advent Technologies (NASDAQ: ADN) has secured an initial order for its Ion Pair High Temperature Proton Exchange Membrane (HT-PEM) electrode assemblies from a major global energy company. The unnamed customer operates in over 100 countries with more than 50,000 employees and is actively involved in energy transition initiatives.
The customer is expanding manufacturing capacity, developing grid infrastructure, and integrating AI technology for utility operations. Advent's Ion Pair HT-PEM technology offers advantages including higher power density and simplified packaging compared to competitors.
Advent Technologies (NASDAQ: ADN) has signed an agreement with a leading U.S.-based semiconductor and wireless technology company to develop and test electrochemical gas sensors using Advent's Ion Pair membrane technology.
The company's High Temperature Proton Exchange Membrane (HT-PEM) technology, developed at Los Alamos National Laboratory, will be used to create miniaturized gas sensors that can potentially be integrated into smartphones. These sensors could have applications in air quality monitoring, food quality assessment, and medical diagnostics, particularly in breath analysis for early cancer detection.
Advent Technologies (NASDAQ: ADN) has established a strategic partnership with Stralis Aircraft to advance hydrogen electric flight technology. The collaboration centers on Advent's proprietary membrane electrode assembly technology being integrated into Stralis' hydrogen electric Beechcraft Bonanza aircraft.
Advent's high-temperature PEM technology enables more efficient engine cooling with smaller radiators, reducing aircraft weight and drag. Stralis reports their system can achieve 10x longer flight distances than battery-electric solutions at lower costs than fossil-fuel aircraft. The hydrogen-electric propulsion system is expected to reduce engine maintenance costs by 40-60% due to fewer moving parts and lower operating temperatures.
Advent Technologies (NASDAQ: ADN) has enhanced its license agreement with TRIAD National Security for the Ion Pair technology, originally developed at Los Alamos National Laboratory. The company has acquired exclusive rights in three key sectors: marine, aviation, and portable power, while maintaining non-exclusive rights in other fields.
The enhanced license covers vessel propulsion, aircraft systems, and portable power units up to 160 lbs. The Ion Pair technology offers advantages through higher power density and simplified packaging, particularly beneficial for defense, homeland security, marine, and aviation applications.
This strategic expansion positions Advent as a leader in High Temperature PEM technology, with plans to commercialize Ion Pair membrane electrode assembly (MEA) technology in collaboration with Los Alamos National Laboratory.
Advent Technologies (NASDAQ: ADN) has appointed Joseph Hosni as Director of Commercial Sales, based in the company's Athens office. Hosni brings over 25 years of experience in technology and infrastructure sales, previously serving as Commercial Director at VEN Engineering. The appointment aligns with Advent's strategic vision, dubbed 'Advent 2.0', focusing on expanding global sales and commercializing their HT-PEM fuel cell technology across multiple sectors including military, aviation, heavy automotive, and marine industries.
Advent Technologies (NASDAQ: ADN) has received a notice from Nasdaq on May 22, 2025, regarding its non-compliance with listing requirements due to delayed financial filings. The company failed to file both its Q1 2025 Form 10-Q (due May 15, 2025) and its 2024 Annual Report Form 10-K (due March 31, 2025). While this notice has no immediate impact on ADN's listing status, the company must submit a compliance plan by June 16, 2025. If Nasdaq accepts the plan, ADN may receive an extension until October 13, 2025, to regain compliance, though acceptance is not guaranteed.
Advent Technologies Holdings (NASDAQ: ADN) has announced the appointment of Dr. Ryan Pavlicek as General Manager of its Livermore facility. Dr. Pavlicek, who previously served with Advent from 2018-2024 in various roles, returns to the company after serving as Technology Manager at the U.S. Department of Energy's Hydrogen and Fuel Cell Technologies Office.
With over 10 years of experience in fuel cell technologies, Dr. Pavlicek played a crucial role in developing the Ion Pair electrode within the DOE L'Innovator program. He holds a PhD in Chemistry from Northeastern University and a B.S. from Carnegie Mellon University. His appointment aims to advance the commercialization of Advent's Ion Pair Technology in the Honey Badger™ product line for battery charging applications.
Advent Technologies (NASDAQ: ADN) has appointed Bryan Holasek as Chief Strategy Officer. Holasek brings over 42 years of experience in technology development and has significant expertise in HT-PEM Fuel Cells through his work at Trenergi Corp. His impressive career includes founding Revolutionary Integrations Group and 369 Power and Energy Group, along with leadership roles at FDE Hydro, Shell TechWorks, and Sikorsky Innovations.
Holasek's background includes contributions to advanced aircraft systems for NASA DARPA and Sikorsky-Boeing projects. He holds a BSE in Mechanical and Aerospace Engineering from Princeton University. The appointment aligns with Advent's goal to enhance commercialization of its fuel cell technology across multiple sectors including aviation, automotive, marine, telecom, and military applications.
Advent Technologies Holdings (NASDAQ: ADN) has received a notice from Nasdaq on April 16, 2025, regarding non-compliance with listing requirements due to the delayed filing of its 2024 Annual Report (Form 10-K). The notice has no immediate impact on the company's stock listing or trading.
The company has been granted 60 calendar days until June 16, 2025, to submit a compliance plan to Nasdaq. If accepted, Advent may receive an extension until October 13, 2025, to regain compliance. The company plans to submit its compliance plan by April 30, 2025, and aims to file the delayed 2024 10-K report by the same date.
Advent Technologies (NASDAQ: ADN) has received approval from Airbus to proceed with Phase Two of their joint benchmarking project focused on optimizing Ion Pair™ Membrane Electrode Assembly (MEA) for hydrogen fuel cells. Following successful performance improvements in Phase One, the collaboration aims to further enhance MEA capabilities.
The project involves sharing expertise in fuel cell stack design, balance of plant components, and testing facilities. Advent's High-Temperature PEM MEAs, operating above 180°C (360°F), address key aviation challenges in thermal management, offering improved performance, passenger capacity, and range compared to low-temperature alternatives.
The initiative targets future hydrogen-powered aircraft development while potentially reducing powertrain system weight and volume through simplified cooling subsystems. Advent believes their HT-PEM technology is superior for multiple applications, including aviation, heavy-duty trucks, automotive, and marine sectors.